AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb IschemiaGlobeNewswire (press release)TOKYO, Jan. 23, 2018 (GLOBE NEWSWIRE) — AnGes, Inc., a biopharmaceutical company focused on developing innovative gene… Continue reading
Dope Magazine |
Singapore Announces Synthetic Medicinal Cannabinoids Research
Dope Magazine Singapore Announces Synthetic Medicinal Cannabinoids Research The five-year program announced by Singapore’s National Research Foundation (NRF) is part of a $25 million-dollar program targeting Synthetic Biology Research Development. The program will … |
FiercePharma |
Vaccine Fails to Help CMV-Positive Stem–Cell Recipients
Managed Care magazine ASP0113 (Astellas Pharma Inc./ Vical Incorporated), an investigational DNA vaccine being developed for cytomegalovirus (CMV)-seropositive hematopoietic stem cell transplant recipients, did not significantly improve overall mortality and CMV end-organ … Vical’s Astellas-partnered CMV vaccine falls short again, this time in stem cell transplant recipientsFiercePharma CMV Vaccine Falls Short in Phase III TrialOncLive |
FiercePharma |
Vaccine Fails to Help CMV-Positive Stem–Cell Recipients
Managed Care magazine ASP0113 (Astellas Pharma Inc./ Vical Incorporated), an investigational DNA vaccine being developed for cytomegalovirus (CMV)-seropositive hematopoietic stem cell transplant recipients, did not significantly improve overall mortality and CMV end-organ … Vical’s Astellas-partnered CMV vaccine falls short again, this time in stem cell transplant recipientsFiercePharma CMV Vaccine Falls Short in Phase III TrialOncLive |